Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Minoxidil helps treat pattern hair loss in both men and women.

The document suggests a need for collaboration, better evidence, and a responsible framework to safely and effectively advance regenerative therapies to clinical use.

The conclusion is that off-label drug use can lead to important medical discoveries and improve patient care.

PRP therapy may effectively treat hair loss, but more research needed.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Six African American women experienced hair loss after switching to a new HIV medication.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Tretinoin is used topically to treat acne, skin aging, and various skin conditions.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Oral medication is necessary to treat scalp fungus in children, with griseofulvin being the usual choice.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Accidental findings have led to new hair treatment discoveries, like using blood pressure and diabetes medications for hair loss and unwanted hair.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Topical minoxidil helps treat hair loss in teens, but more research needed for safe options.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

The paper concludes that drug labels should be clear for all, especially for those with low literacy, and suggests aiming for high comprehension test passing rates with diverse test populations.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

A man developed a serious muscle breakdown condition after using a hair loss medication not known to cause this side effect.

New treatments for severe alopecia areata show promise but lack standard approval.